The current HQL market cap is 332.55M. The company's latest EPS is USD 0.8704 and P/E is 14.88.
Quarter End | |||||
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.44M | 3.39M | 2.29M | 3.02M | 3.5M |
Operating Income | 0 | 0 | 0 | 0 | 0 |
Net Income | -70.48M | 123.05M | 64.53M | -104.6M | 22.35M |
Quarter End | |||||
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 386.98M | 484.17M | 534.19M | 414.73M | 402.6M |
Total Liabilities | 3.33M | 596k | 10.75M | 16.82M | 666k |
Total Equity | 383.65M | 483.57M | 523.44M | 397.9M | 401.93M |
Market Cap | 332.55M |
Price to Earnings Ratio | 14.88 |
Price to Sales Ratio | 95.08 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0.83 |
Dividend Yield | 12.82% |
Shares Outstanding | 25.68M |
Average Volume (1 week) | 97.03k |
Average Volume (1 Month) | 90.93k |
52 Week Change | -8.09% |
52 Week High | 14.37 |
52 Week Low | 11.34 |
Spread (Intraday) | 1.28 (9.51%) |
Company Name | abrdn Life Sciences Investors |
Address |
100 federal street boston, massachusetts 02110 |
Website | https://www.teklacap.com/hql.html |
Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.